Research Status of Neuroprotective therapy for Cerebral Ischemia / 国际脑血管病杂志

ABSTRACT

Although thrombolytic therapy is the only method recommended by the Food and Drug Administration(FDA)for acute ischemic stroke,the time window limits its application.Thus,neuroprotective research,which has a wider application become the focus.This article summarizes the neruoprotective methods in animal researches and clinical trials.